Variability of Physical Assessments in an Older Population That is Overweight or Obese
13. december 2021 opdateret af: Versanis Bio, Inc.
An Observational Study to Assess the Feasibility and Variability of Physical Assessments Performed by People 45 Years of Age or Older Who Are Overweight or Obese
Variability of physical assessments in an older population that is overweight or obese.
Studieoversigt
Status
Afsluttet
Detaljeret beskrivelse
The purpose of this study is to understand difficulty in obtaining physical assessment measurements and assess the variability of these assessments when performed by people who are overweight or obese.
Data collected in this protocol will be used to inform the design of future clinical studies.
Undersøgelsestype
Observationel
Tilmelding (Faktiske)
58
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Florida
-
Jacksonville, Florida, Forenede Stater, 32256
- CNS Healthcare
-
Orlando, Florida, Forenede Stater, 32801
- CNS Healthcare
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
45 år til 90 år (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Prøveudtagningsmetode
Sandsynlighedsprøve
Studiebefolkning
Approximately 60 male and female participants 45 years of age or older who are overweight or obese will be enrolled.
To ensure data are collected from a wide age range, 20 participants will be enrolled per specified age ranges.
The study population must include at least 40% females in the overall study.
Beskrivelse
Inclusion Criteria:
- A written informed consent must be obtained before any study-related assessment is conducted.
- Men and women aged ≥ 45.
- BMI ≥ 30 or BMI ≥ 27 with one or more obesity-associated comorbidities (e.g. hypertension, cardiovascular disease, hyperlipidemia, elevated fasting blood sugar levels, sleep apnea).
- Participants must be able to communicate well with the Investigator and comply with the study requirements.
Exclusion Criteria:
- Participant weight > 150 kg.
- Systolic blood pressure < 90 or > 180 or diastolic blood pressure <50 or >100.
- Heart rate ≤ 50 or ≥ 100.
- Unstable medical condition that would put the participant at risk by performing the study assessments.
- Chronic medical condition rendering participants unable to perform the assessment, e.g., severe knee osteoarthritis.
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Kohorter og interventioner
Gruppe / kohorte |
Intervention / Behandling |
|---|---|
|
Age Range 45 to </= 60
|
The SPPB includes balance stands, a 4-meter walk and 5 timed chair stands.
The 30CST measures the number of times a person can rise from a seated to standing position within 30 seconds.
Grip strength is used as a marker of overall muscle strength.
|
|
Age Range 61 to </= 75
|
The SPPB includes balance stands, a 4-meter walk and 5 timed chair stands.
The 30CST measures the number of times a person can rise from a seated to standing position within 30 seconds.
Grip strength is used as a marker of overall muscle strength.
|
|
Age >/= 76
|
The SPPB includes balance stands, a 4-meter walk and 5 timed chair stands.
The 30CST measures the number of times a person can rise from a seated to standing position within 30 seconds.
Grip strength is used as a marker of overall muscle strength.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
To assess the variability of Short Physical Performance Battery (SPPB, scored from 0-12) results within and between participants.
Tidsramme: Baseline (+7 day window)
|
Baseline (+7 day window)
|
|
To assess the variability of the 30 Second Chair Stand (30CST) results within and between participants.
Tidsramme: Baseline (+7 day window)
|
Baseline (+7 day window)
|
|
To assess the variability of grip strength results (kg) with the use of a hand grip dynamometer within and between participants.
Tidsramme: Baseline (+7 day window)
|
Baseline (+7 day window)
|
|
To assess the variability of the individual Short Physical Performance Battery (SPPB) with subsets (subsets of Balance, Gait and Chair Stand scored 0-4) within participants.
Tidsramme: Baseline (+7 day window)
|
Baseline (+7 day window)
|
|
To compare the variability between the 5 Repetition Sit to Stand (5STS) subtest of the SPPB and 30CST.
Tidsramme: Baseline (+7 day window)
|
Baseline (+7 day window)
|
|
To assess the correlation between bioelectrical impedance analysis (BIA) and waist circumference (WC) as well as body mass index (BMI).
Tidsramme: Baseline (+7 day window)
|
Baseline (+7 day window)
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
20. september 2021
Primær færdiggørelse (Faktiske)
5. november 2021
Studieafslutning (Faktiske)
5. november 2021
Datoer for studieregistrering
Først indsendt
5. november 2021
Først indsendt, der opfyldte QC-kriterier
13. december 2021
Først opslået (Faktiske)
3. januar 2022
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
3. januar 2022
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
13. december 2021
Sidst verificeret
1. december 2021
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- VER201-OBS-032
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
INGEN
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .